Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice.

by Michael Bobardt, Magnus Joakim Hansson, Patrick Mayo, Daren Ure, Robert Foster, Philippe Gallay
Published 2020-01-01

Cyclophilin Inhibitor NV556 Reduces Fibrosis and Hepatocellular Carcinoma Development in Mice With Non-Alcoholic Steatohepatitis

by Joseph Kuo, Sonia Simón Serrano, Sonia Simón Serrano, Alvar Grönberg, Ramin Massoumi, Magnus Joakim Hansson, Philippe Gallay
Published 2019-09-01

Novel Cyclophilin Inhibitor Decreases Cell Proliferation and Tumor Growth in Models of Hepatocellular Carcinoma

by Sonia Simón Serrano, Michele Tavecchio, Alvar Grönberg, Wondossen Sime, Mohamed Jemaà, Steven Moss, Matthew Alan Gregory, Philippe Gallay, Eskil Elmér, Magnus Joakim Hansson, Ramin Massoumi
Published 2021-06-01